VIR

Vir Biotechnology Inc

NASDAQ

Add Alert

VIR

Vir Biotechnology Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Newer

DewDiligence

05/12/20 4:25 PM

Post #45

VIR 1Q20 results—3/31/20 cash=$361.8M:

https://www.globenewswire.com/news-release/2020/05/12/2032224/0/en/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-First-Quarter-2020-Financial-Results.html

DewDiligence

04/15/20 6:34 PM

Post #44

VIR reports interim phase-2 data in HBV:

https://finance.yahoo.com/news/vir-2218-demonstrates-dose-dependent-200110652.html

Vir Biotechnology today announced additional interim data from the ongoing Phase 2 trial… of VIR-2218, an investigational small interfering ribonucleic acid (siRNA) that mediates RNA interference (RNAi) for the treatment of chronic hepatitis B virus (HBV) infection.

…In the ongoing Phase 2 trial, virally suppressed patients on nucleos(t)ide reverse transcriptase inhibitor therapy (n=24) received two subcutaneous 20, 50, 100, or 200 mg doses of VIR-2218 on Day 1 and Day 29. At Week 24, the mean change in HBsAg observed with 20, 50, 100, and 200 mg was -0.76 log10, -0.93 log10, -1.23 log10, and -1.43 log10, respectively [a nice dose response].

Of note, all patients who received the 200 mg dose level achieved a >=1 log10 reduction in HBsAg, with HBeAg- and HBeAg+ patients achieving similar mean declines. There has been no dose-related trend in the frequency of AEs observed during the trial, with the most common AE being headache (n=6; 25%). No patients discontinued the trial due to an AE.

…“Our next step will be to demonstrate whether knockdown of HbsAg can result in high rates of functional cure when VIR-2218 is given in combination with other agents, which is the goal of our next set of trials. We expect the first of those combination trials—combining VIR-2218 with a shortened course of pegylated interferon—to begin dosing patients in the second half of this year.”

VIR-2218 incorporates ALNY’s ESC+ siRNA technology, which VIR claims is a differentiating factor for VIR-2218 compared to other RNAi-based programs in HBV.

CC slides for the above data:
https://investors.vir.bio/static-files/48b8fe3c-79cb-4a80-85e9-ba1f14682abd

VIR is flattish in AH trading, but this doesn’t mean much vis-à-vis the HBV data presented above; lately, VIR has been trading as a COVID-19 play.

Cornball69

04/13/20 12:43 PM

Post #43

nobody pumping this here lol?

DewDiligence

04/06/20 10:34 PM

Post #42

Biocentury expounds on VIR-GSK hookup:

https://www.biocentury.com/article/304842

Pugsieboy

04/06/20 11:17 AM

Post #41

Re: #40: @Rocket10 - When YOU post in any thread RUN LIKE HELL!

When Glaxo runs a deal with any company, run like hell. POS same f ing story every time with them.

Rocket10

04/06/20 11:11 AM

Post #40

Re: #37: @dinogreeves - 45 today most probably.

When YOU post in any thread RUN LIKE HELL!

crudeoil24

04/06/20 10:45 AM

Post #39

Re: #38: @Pugsieboy - Last time I saw a deal with Glaxo

Maybe VIR Ceo took the $250. and went shopping @ Costco.

Pugsieboy

04/06/20 10:04 AM

Post #38

Last time I saw a deal with Glaxo the stock tanked all day. Looks to be the same going on here.

dinogreeves

04/06/20 9:20 AM

Post #37

Re: #36: @crudeoil24 - VIR > GlaxoSmithKline To Make $250M Equity Investment

45 today most probably.

crudeoil24

04/06/20 9:03 AM

Post #36

Re: #30: @dinogreeves - Funded by Bill and Melinda Gates

VIR > GlaxoSmithKline To Make $250M Equity Investment In Vir
8:05 am ET April 6, 2020 (Benzinga) VIR up 29% 37.62
Companies will combine their unique scientific and technical expertise to combat COVID-19 and potential future coronavirus outbreaks

Promising antibody candidates for SARS-CoV-2 to be accelerated into phase 2 clinical trials within the next three to five months

GSK to make equity investment of $250 million in Vir
LONDON and SAN FRANCISCO, April 06, 2020 (GLOBE NEWSWIRE) -- LSE announcement -- GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology, Inc. (NASDAQ:VIR) today announced they have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

DewDiligence

03/04/20 8:08 PM

Post #35

Link to Cowen webcast:

http://wsw.com/webcast/cowen57/vir/

dinogreeves

03/02/20 10:29 AM

Post #34

Conference call premarket tomorrow, this should spike before close.

crudeoil24

03/02/20 7:38 AM

Post #33

Up 7% in PM.

eur06

03/02/20 6:45 AM

Post #32

Re: #29: @dinogreeves - https://www.youtube.com/watch?v=ycrqXJYf1SU

Incredibile.

dinogreeves

03/02/20 12:14 AM

Post #31

39 job openings

https://www.vir.bio/careers/jobs/

dinogreeves

03/02/20 12:10 AM

Post #30

Funded by Bill and Melinda Gates

https://www.vir.bio/pipeline/

dinogreeves

03/01/20 11:54 PM

Post #29

dinogreeves

03/01/20 11:53 PM

Post #28

https://www.nytimes.com/reuters/2020/02/28/world/asia/28reuters-china-health-biotechnology-scangos.html

dinogreeves

03/01/20 11:03 PM

Post #27

dinogreeves

03/01/20 10:52 PM

Post #26

Re: #25: @crudeoil24 - Watching closely tomorrow morning

https://www.cnbc.com/video/2020/01/29/vir-biotechnology-ceo-on-fighting-the-coronavirus-outbreak.html

crudeoil24

03/01/20 9:43 PM

Post #25

Re: #5: @makinezmoney - $VIR: Coming up with a VACINE for CoronaVirus

Watching closely tomorrow morning

VIR

eur06

03/01/20 4:58 PM

Post #24

Re: #23: @dinogreeves - Read this article and you will soon realize

wow...

Quote
Read this article and you will soon realize where this is headed.

https://www.fool.com/investing/2020/02/29/former-biogen-ceo-to-become-biotechs-new-coronavir.aspx

dinogreeves

03/01/20 11:11 AM

Post #23

Read this article and you will soon realize where this is headed.

https://www.fool.com/investing/2020/02/29/former-biogen-ceo-to-become-biotechs-new-coronavir.aspx

Polebarn

02/29/20 7:37 PM

Post #22

Re: #20: @dinogreeves - Conference call premarket on Tuesday, if there is

Lets make it 100 to 200 dollars!!!

dinogreeves

02/29/20 7:33 PM

Post #21

https://finance.yahoo.com/news/least-half-million-people-infected-202153407.html

dinogreeves

02/29/20 11:57 AM

Post #20

Conference call premarket on Tuesday, if there is good news, could send this one right out to the gate to 70-80 dollars.

Polebarn

02/29/20 5:04 AM

Post #19

Re: #18: @dinogreeves - Good end of the close and with buying

Not 100? 200? Lol

dinogreeves

02/28/20 4:36 PM

Post #18

Good end of the close and with buying pressure next week in a blink it will get past 50 dollars.

dinogreeves

02/28/20 10:24 AM

Post #17

VIR back to 70 next week in the cards.

ClayTrader

02/27/20 5:31 PM

Post #16

* * $VIR Video Chart 02-27-2020 * *

Link to Video - click here to watch the technical chart video

starbuxsux

02/27/20 3:17 PM

Post #15

$VIR $AHPI $APT huge Corona moves

zetti

02/27/20 9:41 AM

Post #14

Re: #13: @TheFinalCD - wow crazy

holy Shit. ????

TheFinalCD

02/27/20 8:48 AM

Post #13

Re: #11: @zetti - $VIR holy moly part II

wow crazy

VIR

ClayTrader

02/26/20 5:41 PM

Post #12

* * $VIR Video Chart 02-26-2020 * *

Link to Video - click here to watch the technical chart video

zetti

01/30/20 12:45 PM

Post #11

$VIR holy moly part II

zetti

01/29/20 11:59 AM

Post #10

$VIR holy moly.

Dennisb68

01/28/20 12:08 AM

Post #9

Re: #8: @chico2663 - supposedly they have an anti virus for something similar

Supposedly and something similar? The futuresnare looking good for the opening so it could be interesting.

chico2663

01/27/20 10:52 PM

Post #8

Re: #7: @Dennisb68 - That would be nice but I have seen

supposedly they have an anti virus for something similar

Dennisb68

01/27/20 7:06 PM

Post #7

Re: #5: @makinezmoney - $VIR: Coming up with a VACINE for CoronaVirus

That would be nice but I have seen nothing to indicate they are coming up with vaccine for the virus. There are several companies that would LOVE to come up with a vaccine for the virus. It will be interesting to see how it holds up tomorrow.